Stryker Corporation
SYKStryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −11.8%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) Operating cash flow
Stryker Corporation's operating cash flow for fiscal 2025 was $5.0B, up 18.9% from $4.2B in fiscal 2024. Over the twelve months to 30 September 2026 it was $5.4B. Over the past ten years it has ranged from $981.0M (fiscal 2015) to $5.0B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Stryker Corporation ranks 3rd of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $5.0B | 18.91% |
| FY2024 | $4.2B | 14.31% |
| FY2023 | $3.7B | 41.43% |
| FY2022 | $2.6B | (19.58%) |
| FY2021 | $3.3B | (0.43%) |
| FY2020 | $3.3B | 49.57% |
| FY2019 | $2.2B | (16.05%) |
| FY2018 | $2.6B | 67.42% |
| FY2017 | $1.6B | (18.59%) |
| FY2016 | $1.9B | 95.21% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $1.5B | 15.86% |
| Jun 2026 | $1.3B | 117.04% |
| Mar 2026 | $581.0M | (72.89%) |
| Dec 2025 | $2.1B | 39.16% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ABT Abbott Laboratories compare | $8.9B |
| MDT Medtronic PLC compare | $8.0B |
| SYK Stryker Corporation | $5.4B |
| BSX Boston Scientific Corporation compare | $4.2B |
| PHG Koninklijke Philips N.V. compare | $2.9B |
| GEHC GE HealthCare Technologies Inc. compare | $2.4B |
| EW Edwards Lifesciences Corporation compare | $1.7B |
| DXCM DexCom, Inc. compare | $1.4B |
| STE STERIS plc compare | $1.3B |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement